Are you Dr. Marinier?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1836 South Ave
La Crosse, WI 54601Phone+1 608-782-7300Fax+1 608-375-6208
Summary
- Dr. David Marinier, MD is an oncologist in La Crosse, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Iowa, and Minnesota. He is affiliated with Gundersen Lutheran Medical Center, Gundersen Boscobel Area Hospital and Clinics, and Richland Hospital.
Education & Training
- Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- Loyola University Medical CenterResidency, Internal Medicine, 2004 - 2007
- Loyola University Chicago Stritch School of MedicineClass of 2004
Certifications & Licensure
- IA State Medical License 2013 - 2026
- MN State Medical License 2013 - 2025
- WI State Medical License 2013 - 2025
- IL State Medical License 2004 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
- S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Start of enrollment: 2017 Feb 24
Publications & Presentations
PubMed
- 3 citationsImmune checkpoint inhibitor toxicity and associated outcomes in older patients with cancer.Yacki Hayashi-Tanner, Peter J Polewski, Mamatha Gaddam, Nancy R Fisher, Attila J Kovacs
Journal of Geriatric Oncology. 2022-09-01 - 1 citationsDurable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain Metastasis.Dipesh Uprety, Lubina Arjyal, Yazhini Vallatharasu, Amir Bista, Richard J. Wittchow
Clinical Lung Cancer. 2019-06-13 - PACIFIC: An Ocean of Hope in Patients With Stage III Unresectable Non-Small Cell Lung Cancer.Dipesh Uprety, David E. Marinier
Journal of the National Comprehensive Cancer Network. 2018-05-01